This article will be permanently flagged as inappropriate and made unaccessible to everyone.
Are you certain this article is inappropriate?
Political / Social
This is a list of major whistleblowers from various countries. The individuals below brought attention to abuses of government or large corporations. Many of these whistleblowers were fired from their jobs or prosecuted in the process of shining light on their issue of concern. This list is not exhaustive.
She was, in her professional life, formerly a vice president at UBS Financial Services.
City officials and pension board trustees created a multi-year smear campaign, including filing ethics charges against her and plotting to have her arrested by the San Diego City Police.
The scandal caused widespread fallout in the city's political and financial sectors. Several city officials resigned, including the City Auditor, City Manager, City Treasurer  and the Mayor. The City became the target of two federal investigations and in November 2006, the U.S. Securities and Exchange Commission entered an order sanctioning the City of San Diego for committing securities fraud.
Shipione was eventually proven right about her concerns and received public recognition for her pension system related services from many civic organizations in San Diego.
Courtland Kelley was the head of the General Motors inspection and quality assurance program for many years. He found faults in the Chevrolet Cavilier and the Chevrolet Cobalt, and repeatedly reported them, with little response. He thought his supervisors were more interested in maintaining sales and their own positions than with expensive recalls. In 2003, Kelley sued GM alleging that the company had been slow to address the dangers in its cars and trucks. Even though he lost the court case, Kelley thought that by blowing the whistle he had done the right and proper thing. Faulty ignition switches in the Cobalts, which cut power to the car while in motion, were eventually linked to many crashes resulting in fatalities, starting with a teenager in 2005 who drove her new Cobalt into a tree. In May 2014 the NHTSA fined the company $35 million for failing to recall cars with faulty ignition switches for a decade, despite knowing there was a problem with the switches. Thirteen deaths were attributed to the faulty switches during the time the company failed to recall the cars.
Richard Levernier is an American nuclear power whistleblower. Levernier worked for 23 years as a nuclear security professional, and identified security problems at U.S. nuclear facilities as part of his job. Specifically, after 9/11, he identified problems with contingency planning to protect US nuclear plants from terrorist attacks. He said that the assumption that attackers would both enter and exit from facilities was not valid, since suicide terrorists would not need to exit. In response to this complaint, the U.S. Department of Energy withdrew Levernier's security clearance and he was assigned to clerical work. Levernier approached the United States Office of Special Counsel (OSC), which handles US federal whistleblower matters. It took the OSC four years to vindicate Levernier, ruling that the Department's retaliation was illegal - but the OSC could not reinstate Levernier's security clearance, so he was unable to regain work in nuclear security.
 Eli Lilly pled guilty to actively promoting Zyprexa for off-label uses, particularly for the treatment of dementia in the elderly. The $1.415 billion penalty included an $800 million civil settlement and a $515 million criminal fine—the largest criminal fine for an individual corporation in United States history. Contingent upon the United States receiving the Federal Settlement amount, the nine whistle blowers shared $78,870,877, of the federal share of the civil settlement.
In September 2000, the drug Seroquel received FDA approval for the short-term treatment of schizophrenia, then in 2004, for bipolar depression. James Wetta exposed the company's alleged fraud, where sales reps were promoting the drug for a wide range of less serious disorders which included aggression, Alzheimer's disease, anger management, anxiety, attention deficit hyperactivity disorder, bipolar maintenance, dementia, depression, mood disorder, sleeplessness and post-traumatic stress disorder. Promoting drugs off-label amounts to fraud under the False Claims Act, as the unapproved uses were not medically accepted indications for which the federal and state Medicaid programs provided coverage. Under the Food, Drug and Cosmetics Act, a company must specify the intended use of a product in its new drug application to the FDA. Once the drug is approved by the FDA, the drug may not be marketed or promoted for off-label uses. The civil settlement agreement required AstraZeneca to pay $520 million to the federal government to resolve civil settlements. Jim Wetta provided the information which proved the drug was promoted for conditions other then the FDA medical indication.
United States Department of the Navy, United States Army, United States Air Force, Title 10 of the United States Code, Defense Intelligence Agency
Raymond Hoser, Brian Martin (professor), List of whistleblowers
Goldman Sachs, Charlie Rose, Academy Award, Bullion, Whistleblower
Marketing, Merck & Co., Wyeth, Conflict of interest, Pharmaceutical industry
Barack Obama, Michigan, Democratic Party (United States), Federal Bureau of Investigation, Supreme Court of the United States
U.S. Securities and Exchange Commission, University of California, Berkeley, Deutsche Bank, Reuters, United States District Court for the District of Columbia